Stay updated on BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial
Sign up to get notified when there's something new on the BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial page.

Latest updates to the BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial page
- Check5 days agoChange DetectedAdded an expanded Locations section with state-specific study sites and updated the revision tag to v3.3.3. Removed the HHS Vulnerability Disclosure link and the prior v3.3.2 entry.SummaryDifference1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page shows a new revision label: v3.3.2, replacing the previous v3.2.0. This indicates a minor update to the page version and does not change the study details.SummaryDifference0.0%

- Check43 days agoChange DetectedThe government funding status notice about potential delays and the NIH Clinical Center operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check64 days agoChange DetectedNo significant content changes were detected; the two screenshots appear to show the same study details with only minor UI/layout differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check86 days agoChange DetectedUpdated operating-status notice and version to v3.2.0; removed v3.1.0 tag.SummaryDifference4%

- Check93 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 695500 vs Rituxan in Low Tumor Burden Follicular Lymphoma Clinical Trial page.